Coexistence of anaplastic lymphoma kinase rearrangement in lung adenocarcinoma harbouring epidermal growth factor receptor mutation: A single-center study

Figure 3 The chest computed tomography scan findings (A-H) of case 6#. A: Left upper lung lesion before therapy; B: Left hilar and mediastinal lymph nodes before therapy; C: One month after erlotinib treatment; D: Three months after erlotinib treatment; E: Four months after erlotinib treatment; F: Fifteen days after erlotinib combined with crizotinib treatment; G: The shrinkage of left upper lung lesion after 2 courses of bevacizumab plus pemetrexed combined with carboplatin regimen; H: The shrinkage of left hilar and mediastinal lymph nodes after 2 courses of bevacizumab plus pemetrexed combined with carboplatin regimen.